Chemoinformaics analysis of (Z)-2,6-Dimethylocta-5,7-dien-4-one
| Molecular Weight | 152.237 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 11 |
| Exact Molecular Weight | 152.12 | nRing | 0 |
| Solubility: LogS | -4.941 | nHRing | 0 |
| Solubility: LogP | 4.511 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.558 |
| Synth | 3.174 |
| Natural Product Likeliness | 1.368 |
| NR-PPAR-gamma | 0.413 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.643 |
| Pgp-sub | 0.057 |
| HIA | 0.003 |
| CACO-2 | -4.678 |
| MDCK | 0.0000256 |
| BBB | 0.672 |
| PPB | 0.971083 |
| VDSS | 2.877 |
| FU | 0.0252925 |
| CYP1A2-inh | 0.922 |
| CYP1A2-sub | 0.948 |
| CYP2c19-inh | 0.691 |
| CYP2c19-sub | 0.899 |
| CYP2c9-inh | 0.359 |
| CYP2c9-sub | 0.749 |
| CYP2d6-inh | 0.735 |
| CYP2d6-sub | 0.935 |
| CYP3a4-inh | 0.537 |
| CYP3a4-sub | 0.507 |
| CL | 7.378 |
| T12 | 0.229 |
| hERG | 0.061 |
| Ames | 0.883 |
| ROA | 0.047 |
| SkinSen | 0.914 |
| Carcinogencity | 0.659 |
| EI | 0.984 |
| Respiratory | 0.928 |
| NR-Aromatase | 0.158 |
| Antiviral | No |
| Prediction | 0.944989 |